
|Videos|November 17, 2017
Dr. Becerra on Emerging Treatments in Pancreatic Cancer
Author(s)Carlos Becerra, MD
Carlos Becerra, MD, physician, Texas Oncology, discusses emerging treatments for patients with pancreatic cancer.
Advertisement
Carlos Becerra, MD, physician, Texas Oncology, discusses emerging treatments for patients with pancreatic cancer.
Pancreatic cancer is one of the leading cancer-related deaths, states Beccera. There are currently no good treatment options, although progress has been made.
According to Beccera, newer chemotherapeutic agents and sequencing studies have helped to improve the field. Additionally, the new era of targeted therapy and immunotherapy will provide additional benefit that is needed for patients with metastatic pancreatic cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5



































